Spyre Therapeutics, Inc. (SYRE)
41.25
-1.06
(-2.51%)
USD |
NASDAQ |
Mar 20, 16:00
41.25
0.00 (0.00%)
After-Hours: 20:00
Spyre Therapeutics Accounts Payable (Quarterly) : 8.904M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 1.178M |
| Savara, Inc. | 5.757M |
| Agios Pharmaceuticals, Inc. | 18.36M |
| Tandem Diabetes Care, Inc. | 47.07M |
| ACADIA Pharmaceuticals, Inc. | 10.90M |